Top

Published in:

01-10-2021 | Sleeve Gastrectomy | Original Contributions

Characterizing Timing of Postoperative Complications Following Elective Roux-en-Y gastric Bypass and Sleeve Gastrectomy

Authors: Anna S. Mierzwa, Valentin Mocanu, Gabriel Marcil, Jerry Dang, Noah J. Switzer, Daniel W. Birch, Shahzeer Karmali

Published in: Obesity Surgery | Issue 10/2021

Abstract

Purpose

With the growing prevalence of bariatric procedures performed worldwide, it is important to understand the timing of postoperative complications following bariatric surgery and the differences which may exist between procedures.

Methods

This retrospective study was conducted using the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) data registry from 2017 to 2018. All patients with primary elective Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) procedures were included. The primary outcome was to characterize the timing of postoperative complications for RYGB and SG.

Results

A total of 316,314 patients were identified with 237,066 (74.9%) in the SG cohort and 79,248 (25.1%) in the RYGB cohort. Early complications included myocardial infarction (4.7 ± 6.4 days), cardiac arrest (6.4 ± 8.5 days), pneumonia (6.9 ± 6.9 days), progressive renal insufficiency (8.1 ± 8.1 days), and acute renal failure (8.2 ± 7.6 days). Late complications included Clostridioides difficile infection (11.3 ± 7.8 days), organ space infections (11.7 ± 7.9 days), deep incisional infections (12.4 ± 6.6 days), superficial incisional infections (13.2 ± 6.9 days), and urinary tract infections (14.0 ± 8.4 days). SG patients were more likely to be diagnosed later than RYGB patients with regard to superficial incisional infections (14.0 ± 7.4 days vs 12.5 ± 6.3 days; p = 0.002), organ space infections (12.6 ± 7.8 days vs 10.8 ± 7.9 days; p = 0.001), acute renal failure (9.3 ± 8.1 days vs 6.8 ± 6.8 days; p = 0.03), and pulmonary embolism (13.7 ± 7.5 days vs 11.3 ± 8.0 days; p = 0.003). No significant difference in timing was observed for any other complication by procedures.

Conclusion

We demonstrate that significant differences in timing exist between complications and that these differences also vary by surgical procedure.

Graphical abstract

Inoue Y, Qin B, Poti J, Sokol R, Gordon-Larsen P. Epidemiology of obesity in adults: latest trends. Curr Obes Rep. 2018;7(4):276–88. https://doi.org/10.1007/s13679-018-0317-8.CrossRefPubMed

Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity among adults and youth: United States, 2015–2016. NCHS Data Brief. 2017;288:1–8.

NCD Risk Factor Collaboration. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627–42. https://doi.org/10.1016/S0140-6736(17)32129-3

Blüher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15(5):288–98. https://doi.org/10.1038/s41574-019-0176-8.CrossRefPubMed

Twells LK, Janssen I, Kuk JL. Canadian adult obesity clinical practice guidelines: epidemiology of adult obesity. https://obesitycanada.ca/guidelines/epidemiology. Published 2020. Accessed 20 Sept 2020.

Mehta A, Marso SP, Neeland IJ. Liraglutide for weight management: a critical review of the evidence. Obes Sci Pract. 2017;3(1):3–14. https://doi.org/10.1002/osp4.84.CrossRefPubMed

Salminen P, Helmiö M, Ovaska J, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss at 5 years among patients with morbid obesity: the SLEEVEPASS randomized clinical trial. JAMA. 2018;319(3):241–54. https://doi.org/10.1001/jama.2017.20313.CrossRefPubMedPubMedCentral

Anvari M, Lemus R, Breau R. A landscape of bariatric surgery in Canada: for the treatment of obesity, type 2 diabetes and other comorbidities in adults. Can J Diabetes. 2018;42(5):560–7. https://doi.org/10.1016/j.jcjd.2017.12.007.CrossRefPubMed

Livingston EH. Procedure incidence and in-hospital complication rates of bariatric surgery in the United States. Am J Surg. 2004;188(2):105–10. https://doi.org/10.1016/j.amjsurg.2004.03.001.CrossRefPubMed

10.

Mingrone G, Panunzi S, De Gaetano A, et al. Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2021;397(10271):293–304. https://doi.org/10.1016/S0140-6736(20)32649-0.CrossRefPubMed

11.

Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–76. https://doi.org/10.1056/NEJMoa1200225.CrossRefPubMedPubMedCentral

12.

Chang SH, Freeman NLB, Lee JA, et al. Early major complications after bariatric surgery in the USA, 2003–2014: a systematic review and meta-analysis. Obes Rev. 2018;19(4):529–37. https://doi.org/10.1111/obr.12647.CrossRefPubMed

13.

Kizy S, Jahansouz C, Downey MC, et al. National trends in bariatric surgery 2012–2015: demographics, procedure selection, readmissions, and cost. Obes Surg. 2017;27(11):2933–9. https://doi.org/10.1007/s11695-017-2719-1.CrossRefPubMed

14.

Dang JT, Shelton J, Mocanu V, et al. Trends and outcomes of laparoscopic sleeve gastrectomy between 2015 and 2018 in the USA and Canada. Obes Surg. 2021;31(2):675–81. https://doi.org/10.1007/s11695-020-04939-w.CrossRefPubMed

15.

Thompson JS, Baxter BT, Allison JG, Johnson FE, Lee KK, Park WY. Temporal patterns of postoperative complications. Arch Surg. 2003;138(6):596–603. https://doi.org/10.1001/archsurg.138.6.596.CrossRefPubMed

16.

Sonnenberg EM, Reinke CE, Bartlett EK, et al. Wind, water, wound, walk—do the data deliver the dictum? J Surg Educ. 2015;72(1):164–9. https://doi.org/10.1016/j.jsurg.2014.05.019.CrossRefPubMed

17.

Henkel DS, Mora-Pinzon M, Remington PL, et al. Trends in the prevalence of severe obesity and bariatric surgery access: a state-level analysis from 2011 to 2014. J Laparoendosc Adv Surg Tech A. 2017;27(7):669–75. https://doi.org/10.1089/lap.2017.0157.CrossRefPubMed

18.

Khan S, Rock K, Baskara A, et al. Trends in bariatric surgery from 2008 to 2012. Am J Surg. 2016;211(6):1041–6. https://doi.org/10.1016/j.amjsurg.2015.10.012.CrossRefPubMed

19.

Nguyen NT, Masoomi H, Magno CP, et al. Trends in use of bariatric surgery, 2003–2008. J Am Coll Surg. 2011;213(2):261–6. https://doi.org/10.1016/j.jamcollsurg.2011.04.030.CrossRefPubMed

20.

Mocanu V, Dang JT, Sun W, et al. An evaluation of the modern North American bariatric surgery landscape: current trends and predictors of procedure selection. Obes Surg. 2020;30(8):3064–72. https://doi.org/10.1007/s11695-020-04667-1a.CrossRefPubMed

21.

Wallenius V, Dirinck E, Fandriks L, Maleckas A, le Roux CW, Thorell A. Glycemic control after sleeve gastrectomy and Roux-en-Y gastric bypass in obese subjects with type 2 diabetes mellitus. Obes Surg. 2018;28(6):1461–72. https://doi.org/10.1007/s11695-017-3061-3.CrossRefPubMed

22.

Peterli R, Wolnerhanssen BK, Peters T, Vetter D, Kroll D, Borbely Y, Schultes B, Beglinger C, Drewe J, Schiesser M, Nett P, Bueter M. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA. 2018;319(3):255–65. https://doi.org/10.1001/jama.2017.20897.CrossRefPubMedPubMedCentral

23.

Climent E, Benaiges D, Pedro-Botet J, Goday A, Sola I, Ramon JM, Flores-Le Roux JA, Checa MA. Laparoscopic Roux-en-Y gastric bypass vs laparoscopic sleeve gastrectomy for morbid obesity: a systematic review and meta-analysis of lipid effect at one year post surgery. Minerva Endocrinol. 2018;43(1):87–100. https://doi.org/10.23736/S0391-1977.17.02627-X.CrossRefPubMed

24.

Zhao H, Jiao L. Comparative analysis for the effect of Roux-en-Y gastric bypass vs sleeve gastrectomy in patients with morbid obesity: Evidence from 11 randomized clinical trials (meta-analysis). Int J Surg. 2019;72:216–23. https://doi.org/10.1016/j.ijsu.2019.11.013.CrossRefPubMed

25.

Melissas J, Stavroulakis K, Tzikoulis V, Peristeri A, Papadakis JA, Pazouki A, Khalaj A, Kabir A. Sleeve gastrectomy vs Roux-en-Y gastric bypass. Data from IFSO-European chapter center of excellence program. Obes Surg. 2017;27(4):847–55. https://doi.org/10.1007/s11695-016-2395-6

26.

Lager CJ, Esfandiari NH, Subauste AR, Kraftson AT, Brown MB, Cassidy RB, Nay CK, Lockwood AL, Varban OA, Oral EA. Roux-en-Y gastric bypass vs sleeve gastrectomy: balancing the risk of surgery with the benefits of weight loss. Obes Surg. 2017;27(1):154–61. https://doi.org/10.1007/s11695-016-2265-2.CrossRefPubMed

27.

Moyes LH, Leitch EF, McKee RF, Anderson JH, Horgan PG, McMillan DC. Preoperative systemic inflammation predicts postoperative infectious complications in patients undergoing curative resection for colorectal cancer. Br J Cancer. 2009;100:1236–9. https://doi.org/10.1038/sj.bjc.6604997.CrossRefPubMedPubMedCentral

28.

Jochum SB, Kistner M, Wood EH, Hoscheit M, Nowak L, Poirier J, Eberhardt M, Saclarides TJ, Hayden DM. Is sarcopenia a better predictor of complications than body mass index? Sarcopenia and surgical outcomes in patients with rectal cancer. Colorectal Dis. 2019;21(12):1372–8. https://doi.org/10.1111/codi.14751.CrossRefPubMed

29.

Angele MK, Faist E. Clinical review: immunodepression in the surgical patient and increased susceptibility to infection. Crit Care. 2002;6:298. https://doi.org/10.1186/cc1514.CrossRefPubMedPubMedCentral

30.

Albeladi B, Bourbao-Tournois C, Huten N. Short- and midterm results between laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy for the treatment of morbid obesity. J Obes. 2013;2013:934653. https://doi.org/10.1155/2013/934653.

31.

Silecchia G, Iossa A. Complications of staple line and anastomoses following laparoscopic bariatric surgery. Ann Gastroenterol. 2018;31(1):56–64. https://doi.org/10.20524/aog.2017.0201.CrossRefPubMed

32.

Sørensen LT, Hemmingsen U, Kallehave F, Wille-Jørgensen P, Kjærgaard J, NørgaardMøller L, Jorgenson T. Risk factors for tissue and wound complications in gastrointestinal surgery. Ann Surg. 2005;241(4):654–8. https://doi.org/10.1097/01.sla.0000157131.84130.12.CrossRefPubMedPubMedCentral

33.

Watanabe A, Kohnoe S, Shimabukuro R, et al. Risk factors associated with surgical site infection in upper and lower gastrointestinal surgery. Surg Today. 2008;38:404–12. https://doi.org/10.1007/s00595-007-3637-y.CrossRefPubMed

34.

Wilson SE, Faulkner K. Impact of anatomical site on bacteriological and clinical outcomes in the management of intra-abdominal infections. Am Surg. 1998;64(5):402–7.PubMed

35.

Małczak P, Pisarska M, Piotr M, Wysocki M, Budzyński A, Pędziwiatr M. Enhanced recovery after bariatric surgery: systematic review and meta-analysis. Obes Surg. 2017;27(1):226–35. https://doi.org/10.1007/s11695-016-2438-z.CrossRefPubMed

36.

Lam J, Suzuki T, Bernstein D, et al. An ERAS protocol for bariatric surgery: is it safe to discharge on post-operative day 1? Surg Endosc. 2019;33(2):580–6. https://doi.org/10.1007/s00464-018-6368-9.CrossRefPubMed

37.

Surve A, Cottam D, Zaveri H, et al. Does the future of laparoscopic sleeve gastrectomy lie in the outpatient surgery centre? A retrospective study of the safety of 3162 outpatient sleeve gastrectomies. Surg Obes Relat Dis. 2018;14:1442–7. https://doi.org/10.1016/j.soard.2018.05.027.CrossRefPubMed

Title: Characterizing Timing of Postoperative Complications Following Elective Roux-en-Y gastric Bypass and Sleeve Gastrectomy
Authors: Anna S. Mierzwa
Valentin Mocanu
Gabriel Marcil
Jerry Dang
Noah J. Switzer
Daniel W. Birch
Shahzeer Karmali
Publication date: 01-10-2021
Publisher: Springer US
Keywords: Sleeve Gastrectomy
Bariatric Surgery
Bariatric Surgery
Myocardial Infarction
Clostridioides Difficile
Urinary Tract Infection
Cardiopulmonary Resuscitation
Published in: Obesity Surgery / Issue 10/2021
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI: https://doi.org/10.1007/s11695-021-05638-w

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Characterizing Timing of Postoperative Complications Following Elective Roux-en-Y gastric Bypass and Sleeve Gastrectomy

Abstract

Purpose

Methods

Results

Conclusion

Graphical abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Graphical abstract

Please log in to get access to this content

Other articles of this Issue 10/2021

Improvement of Renal Function After Bariatric Surgery: a Systematic Review and Meta-analysis

Impact of Self-Monitoring on Weight Loss After Bariatric Surgery

How do Patients Access Bariatric Surgery? An Analysis of Referrals to a Large Academic Medical Center

The Need and Safety of Mineral Supplementation in Adults with Obesity Post Bariatric Surgery—Sleeve Gastrectomy (SG)

The Gastric Bypass and Fundoplication in Bariatric Surgery: the Comments on Published Papers and Our Classification of Combination Procedures

Multivariate Analysis of the Failure Risk of First Tracheal Intubation Attempt in a Population of Patients Scheduled for Bariatric Surgery